Suppr超能文献

挽救性机器人辅助根治性膀胱切除术对于有盆腔放疗史的患者是安全的。

Salvage robotic-assisted radical cystectomy is safe in patients with history of pelvic irradiation.

作者信息

Kovacic James, Dhar Ankur, Kam Jonathan, Shepherd Andrew, Goolam Ahmed, Winter Matthew

机构信息

North Shore Urology Research Group, Sydney, Australia.

Department of Urology, Royal North Shore Hospital, Sydney, Australia.

出版信息

Curr Urol. 2025 Jul;19(4):286-292. doi: 10.1097/CU9.0000000000000279. Epub 2025 Apr 11.

Abstract

OBJECTIVES

To describe the surgical approach and perioperative outcomes of a multicenter series evaluating a robotic-assisted approach to radical cystectomy with total intracorporeal urinary diversion in the setting of prior pelvic radiotherapy.

MATERIALS AND METHODS

We analyzed our prospective cystectomy database for patients who underwent robotic-assisted radical cystectomy for bladder cancer after radiotherapy between 2018 and 2022. Demographic information and data regarding preoperative factors including stage of disease, preoperative hydronephrosis, and history of pelvic radiotherapy were collected via review of electronic medical records. All operations were performed by 1 of 2 experienced urologists using the da Vinci X, Xi, or Si surgical platforms.

RESULTS

Ten patients were identified for this study. The median age of participants was 73.5 years (range, 41-84 years). The median American Society of Anesthesiologists classification score was 3 (range, 3-4). The median Charlson Comorbidity Index was 6 (range, 2-12). Among the patients, 4 out of 10 patients (40%) had muscle invasive bladder cancer before salvage surgery. Intracorporeal ileal conduit urinary diversion was performed in 8 patients, whereas 2 patients underwent intracorporeal neobladder formation. Median intraoperative blood loss was 250 mL (range, 150-600 mL), and median operative duration was 390 minutes (range, 195-450 minutes). The overall 30-day complication rate was 60% with a Clavien-Dindo grade ≥3 complication rate of 15%. Perioperative mortality was 0%. Median duration of follow-up was 210 days (range, 60-1580 days).

CONCLUSIONS

This series describing the outcomes of salvage robotic-assisted radical cystectomy using total intracorporeal urinary diversion demonstrates the safety of this technique. Further studies with long-term follow-up, including oncological outcomes, are required to support the widespread adoption of this procedure.

摘要

目的

描述多中心系列研究中,在既往盆腔放疗背景下,采用机器人辅助根治性膀胱切除术加完全体内尿流改道的手术方法及围手术期结果。

材料与方法

我们分析了2018年至2022年间接受放疗后机器人辅助根治性膀胱切除术治疗膀胱癌患者的前瞻性膀胱切除术数据库。通过查阅电子病历收集人口统计学信息以及术前因素数据,包括疾病分期、术前肾积水和盆腔放疗史。所有手术均由2名经验丰富的泌尿外科医生中的1名,使用达芬奇X、Xi或Si手术平台进行。

结果

本研究共纳入10例患者。参与者的中位年龄为73.5岁(范围41 - 84岁)。美国麻醉医师协会分类评分中位数为3(范围3 - 4)。查尔森合并症指数中位数为6(范围2 - 12)。在这些患者中,10例患者中有4例(40%)在挽救性手术前患有肌层浸润性膀胱癌。8例患者进行了体内回肠导管尿流改道,而2例患者进行了体内新膀胱成形术。术中中位失血量为250 mL(范围150 - 600 mL),中位手术时间为390分钟(范围195 - 450分钟)。30天总体并发症发生率为60%,Clavien - Dindo≥3级并发症发生率为15%。围手术期死亡率为0%。中位随访时间为210天(范围60 - 1580天)。

结论

本系列描述了采用完全体内尿流改道的挽救性机器人辅助根治性膀胱切除术的结果,证明了该技术的安全性。需要进行包括肿瘤学结果在内的长期随访的进一步研究,以支持该手术的广泛应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca5/12321446/44e499eef62a/curr-urol-19-286-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验